This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart Failure

Volume: 2, Issue: 2, Pages: 73 - 73
Published: Jan 1, 2020
Abstract
Recognition that neurohormonal activation plays a central role in the pathogenesis of heart failure (HF) led to the development of angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers, mineralocorticoid receptor antagonists and beta blockers. While there has been substantial success with these neurohormonal blocking drugs in patients with HF with reduced ejection fraction (HFrEF), persistently high rates of morbidity...
Paper Details
Title
Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart Failure
Published Date
Jan 1, 2020
Volume
2
Issue
2
Pages
73 - 73
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.